A new treatment combining ReCET and semaglutide could eliminate the need for insulin in type 2 diabetes, with 86% of ...

Oral semaglutide is currently approved under the brand name Rybelsus ® as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Based on these findings, ...

On Monday, Novo Nordisk A/S (NYSE:NVO) released the headline results from the SOUL Phase 3 cardiovascular outcomes trial.

Diabetes is becoming more widespread, yet receiving a diagnosis can still be scary. Expert endocrinologists share what you ...

As global populations age, the prevalence of type 2 diabetes and its associated complications, such as sarcopenia, continues to rise.

A new, reassuring study finds that men can take the diabetes drug metformin without worrying that their offspring will suffer ...

Early screening can prevent vision loss in diabetic patients, says ABHI SINGHAL There are over 101 million people affected ...

The diabetes drug metformin does not appear to promote birth defects. Men taking metformin did not have an increased risk of ...

The incidence of type 2 diabetes in Australian adults has been declining since 2010, but the same cannot be said of ...

New research has linked ultra-processed foods to type 2 diabetes. How will this latest blow impact the food and beverage ...

Healthier You: NHS Diabetes Prevention Programme - gestational diabetes mellitus (GDM) information for healthcare profe ...